Skip to Content

Regadenoson use while Breastfeeding

Drugs containing Regadenoson: Lexiscan

Medically reviewed by Drugs.com. Last updated on Feb 7, 2021.

Regadenoson Levels and Effects while Breastfeeding

Summary of Use during Lactation

No information is available on the use of regadenoson during breastfeeding. To avoid exposure of the infant to regadenoson, nursing mothers should avoid breastfeeding for 10 hours after drug administration.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Substance Identification

Substance Name

Regadenoson

CAS Registry Number

875148-45-1 313348-27-5

Drug Class

  • Breast Feeding
  • Lactation
  • Adenosine A2 Receptor Agonists
  • Diagnostic Agents
  • Purines
  • Pyrazoles

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.